When you start on a disease-modifying therapy (DMT) to treat relapsing multiple sclerosis (RMS), you may be looking for something that allows you to have some flexibility.
Taking Rebif® (interferon beta-1a) 3 times weekly, at least 48 hours apart, as prescribed by your healthcare provider, means that you can pick the days that work best with your schedule—you can even choose to keep your weekends injection free.
Mon | Tue | Wed | Thurs | Fri | Sat | Sun |
✓ | ✓ | ✓ | Injection free weekends |
M | T | W | Th | F | S | Su |
✓ | ✓ | ✓ | Injection free weekends |
Please see Important Safety Information below, the Rebif® Medication Guide and Prescribing Information, and speak with your healthcare provider for more information.
If you would prefer to receive a printed version of the treatment tracker, call MS LifeLines® at 1-877-447-3243.
IMPORTANT SAFETY INFORMATION AND INDICATION
Important Safety Information
Do not take Rebif if you are allergic to interferon beta, human albumin, or any of the ingredients in Rebif.
Rebif can cause serious side effects. Tell your healthcare provider right away if you have any of the symptoms listed below while taking Rebif.
Before you take Rebif, tell your healthcare provider if you have or have had any of the following conditions:
Tell your healthcare provider about all medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.
The most common side effects of Rebif include:
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Rebif. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.
Indication
Rebif® (interferon beta-1a) is a prescription medicine used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is not known if Rebif is safe and effective in children.
Please see Rebif® Prescribing Information and Medication Guide.